Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin-associated protein 17-1 is a structural protein belonging to the ultrahigh sulfur subgroup of the keratin-associated protein (KAP) family[1]. KAPs form an interfilamentous matrix around keratin intermediate filaments, contributing to the rigidity and resilience of hair shafts through extensive disulfide cross-linking[1]. KRTAP17-1 is primarily expressed in the hair cortex and is not recognized as a classical receptor, enzyme, transporter, or therapeutic target[1]. Its primary biological function is the stabilization and structural formation of hair fibers, and mutations or altered expression may be genetically associated with conditions like limited scleroderma, but the mechanistic details remain unclear and no known drugs target this protein[1]. KRTAP17-1 is not a therapeutic target or receptor but a structural component in hair[1]. It is part of the "ultrahigh sulfur" KAPs, notable for their cysteine-rich sequences and involvement in hair structure[1]. Clinical significance is limited; primarily studied in the context of hair biology and some genetic associations, but not as a direct disease target[1]. There is no evidence for drug targeting, biomarker use, or known safety concerns. Studies on related family members (e.g., KRTAP5-5) suggest potential indirect roles in cytoskeletal regulation in cancer biology, but there is no direct evidence involving KRTAP17-1 itself[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin-associated protein 17-1 (KRTAP17-1).